News - Gilead Sciences, Respiratory and Pulmonary

Filter

Popular Filters

Gilead abandons development of PAH drug cicletanine

23-08-2012

US biotech firm Gilead Sciences (Nasdaq: GILD), the world leader in HIV/AIDS drugs, has discontinued…

BiotechnologycicletanineGilead SciencesRare diseasesResearchRespiratory and Pulmonary

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top